AFTD Webinar: How to Find a Genetic Counselor

FTD has a stronger genetic risk than other dementias. While not all FTD is inherited, understanding whether the FTD in your family is genetic is crucial: it can confirm the diagnosis, inform care choices, and help you anticipate future care needs, plan financially, and allow relatives to make informed decisions around family and future planning.…

Read More

Regional, Virtual Meet & Greet for Idaho, Oregon, and Washington for Parents Caring for a Spouse With FTD

Graphic: Virtual Meet & Greet

Join and learn from others who understand the FTD journey at this virtual, regional AFTD Meet & Greet event for parents whose spouses are diagnosed with FTD in Idaho, Oregon, and Washington, hosted by AFTD volunteer Julie Motschenbacher, on April 28, 2025. RSVP by emailing Julie at m13family at gmail.com. We encourage you to download this flyer and…

Read More

Review Article Explores Lived Experiences of Ceasing Driving Due to Young-Onset Dementia

Text: Review article explores lived experience of ceasing driving due to young-onset dementia | Background: A woman drives her car

A review article published in the journal BMC Geriatrics explores and summarizes the lived experiences of ceasing driving due to young-onset dementias like FTD, finding that families are often left to navigate the associated challenges on their own. Driving Often Cessation Occurs During Peak of Family Life and Career Dementias like FTD are progressive conditions…

Read More

The 20th Annual GFS Memorial Golf Outing

The 20th annual GFS Memorial Golf Outing will be held on August 2, 2025 at the Lost Nation Golf Course in Willoughby, OH. The event will feature a shotgun start, four person scramble format, closest to the pin and most accurate drive contests, door prizes, a raffle and steak dinner. All proceeds to benefit AFTD’s…

Read More

Perspectives in FTD Research Webinar: AFTD and You – Partners in Drug Development

How does a great scientific idea become an effective treatment? It’s a long and complicated process! Drug development involves many key players, including researchers, companies, regulators, funders, patient advocacy organizations like AFTD and, importantly, community members with lived experience of FTD. The field of FTD has made exciting progress in the past decade, with treatments…

Read More

Statement from The Association for Frontotemporal Degeneration on the Need for Robust and Consistent Medical Research Funding

The Association for Frontotemporal Degeneration (AFTD) continues to urgently advocate for robust and consistent funding for the National Institutes of Health (NIH) in FY 2026 appropriations. Despite being the most common dementia diagnosed in people under 60 years, FTD currently has no effective treatment to prevent its onset and slow its progression. Families and their…

Read More